Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.6632
-0.0114 (-1.69%)
At close: Aug 7, 2025, 4:00 PM
0.6832
+0.0200 (3.02%)
Pre-market: Aug 8, 2025, 8:23 AM EDT
Tenaya Therapeutics Market Cap
Tenaya Therapeutics has a market cap or net worth of $107.88 million as of August 8, 2025. Its market cap has decreased by -62.56% in one year.
Market Cap
107.88M
Enterprise Value
48.42M
1-Year Change
-62.56%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since July 30, 2021, Tenaya Therapeutics's market cap has decreased from $603.63M to $107.88M, a decrease of -82.13%. That is a compound annual growth rate of -34.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 109.74M | -3.13% |
| Dec 31, 2024 | 113.29M | -48.67% |
| Dec 29, 2023 | 220.68M | 71.58% |
| Dec 30, 2022 | 128.62M | -83.56% |
| Dec 31, 2021 | 782.28M | 29.59% |
| Jul 30, 2021 | 603.63M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.04B |
| Johnson & Johnson | 410.84B |
| AbbVie | 346.78B |
| AstraZeneca | 228.71B |
| Abbott Laboratories | 227.88B |
| UnitedHealth Group | 222.96B |
| Novartis AG | 221.76B |
| Novo Nordisk | 200.63B |